139 research outputs found
Health care workersâ experiences during the COVID-19 pandemic: a scoping review
Background:
COVID-19 has challenged health systems worldwide, especially the health workforce, a pillar crucial for health systems resilience. Therefore, strengthening health system resilience can be informed by analyzing health care workersâ (HCWs) experiences and needs during pandemics. This review synthesizes qualitative studies published during the first year of the COVID-19 pandemic to identify factors affecting HCWsâ experiences and their support needs during the pandemic. This review was conducted using the Joanna Briggs Institute methodology for scoping reviews. A systematic search on PubMed was applied using controlled vocabularies. Only original studies presenting primary qualitative data were included.
Results:
161 papers that were published from the beginning of COVID-19 pandemic up until 28th March 2021 were included in the review. Findings were presented using the socio-ecological model as an analytical framework. At the individual level, the impact of the pandemic manifested on HCWsâ well-being, daily routine, professional and personal identity. At the interpersonal level, HCWsâ personal and professional relationships were identified as crucial. At the institutional level, decision-making processes, organizational aspects and availability of support emerged as important factors affecting HCWsâ experiences. At community level, community morale, norms, and public knowledge were of importance. Finally, at policy level, governmental support and response measures shaped HCWsâ experiences. The review identified a lack of studies which investigate other HCWs than doctors and nurses, HCWs in non-hospital settings, and HCWs in low- and lower middle income countries.
Discussion:
This review shows that the COVID-19 pandemic has challenged HCWs, with multiple contextual factors impacting their experiences and needs. To better understand HCWsâ experiences, comparative investigations are needed which analyze differences across as well as within countries, including differences at institutional, community, interpersonal and individual levels. Similarly, interventions aimed at supporting HCWs prior to, during and after pandemics need to consider HCWsâ circumstances.
Conclusions:
Following a context-sensitive approach to empowering HCWs that accounts for the multitude of aspects which influence their experiences could contribute to building a sustainable health workforce and strengthening health systems for future pandemics.Peer Reviewe
Assessing COVID-19 through the lens of health systems' preparedness: time for a change.
The last months have left no-one in doubt that the COVID-19 pandemic is exerting enormous pressure on health systems around the world, bringing to light the sub-optimal resilience of even those classified as high-performing. This makes us re-think the extent to which we are using the appropriate metrics in evaluating health systems which, in the case of this pandemic, might have masked how unprepared some countries were. It also makes us reflect on the strength of our solidarity as a global community, as we observe that global health protection remains, as this pandemic shows, focused on protecting high income countries from public health threats originating in low and middle income countries. To change this course, and in times like this, all nations should come together under one umbrella to respond to the pandemic by sharing intellectual, human, and material resources. In order to work towards stronger and better prepared health systems, improved and resilience-relevant metrics are needed. Further, a new model of development assistance for health, one that is focused on stronger and more resilient health systems, should be the world's top priority
Seroprevalence and risk factors of COVID-19 in healthcare workers from 11 African countries: a scoping review and appraisal of existing evidence.
A better understanding of serological data and risk factors for coronavirus disease 2019 (COVID-19) infection in healthcare workers (HCWs) is especially important in African countries where human resources and health services are more constrained. We reviewed and appraised the evidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence and its risk factors in HCWs in Africa to inform response and preparedness strategies during the SARS-CoV-2 pandemic. We followed the Preferred Reporting Items for systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guidelines in this scoping review. Databases including PubMed, Embase and preprint servers were searched accordingly from the start of the COVID-19 pandemic to 19 April 2021. Our search yielded 12 peer-reviewed and four pre-print articles comprising data on 9223 HCWs from 11 countries in Africa. Seroprevalence varied widely and ranged from 0% to 45.1%. Seropositivity was associated with older age, lower education, working as a nurse/non-clinical HCW or in gynaecology, emergency, outpatient or surgery departments. Asymptomatic rates were high and half of the studies recommended routine testing of HCWs. This scoping review found a varying but often high SARS-CoV-2 seroprevalence in HCWs in 11 African countries and identified certain risk factors. COVID-19 public health strategies for policy and planning should consider these risk factors and the potential for high seroprevalence among HCWs when prioritizing infection prevention and control measures and vaccine deployment
Comparative effectiveness of contact tracing interventions in the context of the COVID-19 pandemic: a systematic review
Contact tracing is a non-pharmaceutical intervention (NPI) widely used in the control of the COVID-19 pandemic. Its effectiveness may depend on a number of factors including the proportion of contacts traced, delays in tracing, the mode of contact tracing (e.g. forward, backward or bidirectional contact training), the types of contacts who are traced (e.g. contacts of index cases or contacts of contacts of index cases), or the setting where contacts are traced (e.g. the household or the workplace). We performed a systematic review of the evidence regarding the comparative effectiveness of contact tracing interventions. 78 studies were included in the review, 12 observational (ten ecological studies, one retrospective cohort study and one pre-post study with two patient cohorts) and 66 mathematical modelling studies. Based on the results from six of the 12 observational studies, contact tracing can be effective at controlling COVID-19. Two high quality ecological studies showed the incremental effectiveness of adding digital contact tracing to manual contact tracing. One ecological study of intermediate quality showed that increases in contact tracing were associated with a drop in COVID-19 mortality, and a pre-post study of acceptable quality showed that prompt contact tracing of contacts of COVID-19 case clusters / symptomatic individuals led to a reduction in the reproduction number R. Within the seven observational studies exploring the effectiveness of contact tracing in the context of the implementation of other non-pharmaceutical interventions, contact tracing was found to have an effect on COVID-19 epidemic control in two studies and not in the remaining five studies. However, a limitation in many of these studies is the lack of description of the extent of implementation of contact tracing interventions. Based on the results from the mathematical modelling studies, we identified the following highly effective policies: (1) manual contact tracing with high tracing coverage and either medium-term immunity, highly efficacious isolation/quarantine and/ or physical distancing (2) hybrid manual and digital contact tracing with high app adoption with highly effective isolation/ quarantine and social distancing, (3) secondary contact tracing, (4) eliminating contact tracing delays, (5) bidirectional contact tracing, (6) contact tracing with high coverage in reopening educational institutions. We also highlighted the role of social distancing to enhance the effectiveness of some of these interventions in the context of 2020 lockdown reopening. While limited, the evidence from observational studies shows a role for manual and digital contact tracing in controlling the COVID-19 epidemic. More empirical studies accounting for the extent of contact tracing implementation are required.Peer Reviewe
Health in times of uncertainty in the eastern Mediterranean region, 1990â2013: a systematic analysis for the Global Burden of Disease Study 2013
Background The eastern Mediterranean region is comprised of 22 countries: Afghanistan, Bahrain, Djibouti,
Egypt, Iran, Iraq, Jordan, Kuwait, Lebanon, Libya, Morocco, Oman, Pakistan, Palestine, Qatar, Saudi Arabia,
Somalia, Sudan, Syria, Tunisia, the United Arab Emirates, and Yemen. Since our Global Burden of Disease Study
2010 (GBD 2010), the region has faced unrest as a result of revolutions, wars, and the so-called Arab uprisings. The
objective of this study was to present the burden of diseases, injuries, and risk factors in the eastern Mediterranean
region as of 2013.
Methods GBD 2013 includes an annual assessment covering 188 countries from 1990 to 2013. The study covers
306 diseases and injuries, 1233 sequelae, and 79 risk factors. Our GBD 2013 analyses included the addition of new
data through updated systematic reviews and through the contribution of unpublished data sources from
collaborators, an updated version of modelling software, and several improvements in our methods. In this
systematic analysis, we use data from GBD 2013 to analyse the burden of disease and injuries in the eastern
Mediterranean region specifi cally.
Findings The leading cause of death in the region in 2013 was ischaemic heart disease (90¡3 deaths per 100 000 people),
which increased by 17¡2% since 1990. However, diarrhoeal diseases were the leading cause of death in Somalia
(186¡7 deaths per 100 000 people) in 2013, which decreased by 26¡9% since 1990. The leading cause of disabilityadjusted
life-years (DALYs) was ischaemic heart disease for males and lower respiratory infection for females. High
blood pressure was the leading risk factor for DALYs in 2013, with an increase of 83¡3% since 1990. Risk factors for
DALYs varied by country. In low-income countries, childhood wasting was the leading cause of DALYs in Afghanistan,
Somalia, and Yemen, whereas unsafe sex was the leading cause in Djibouti. Non-communicable risk factors were the
leading cause of DALYs in high-income and middle-income countries in the region. DALY risk factors varied by age,
with child and maternal malnutrition aff ecting the younger age groups (aged 28 days to 4 years), whereas high bodyweight and systolic blood pressure aff ected older people (aged 60â80 years). The proportion of DALYs attributed
to high body-mass index increased from 3¡7% to 7¡5% between 1990 and 2013. Burden of mental health problems
and drug use increased. Most increases in DALYs, especially from non-communicable diseases, were due to
population growth. The crises in Egypt, Yemen, Libya, and Syria have resulted in a reduction in life expectancy; life
expectancy in Syria would have been 5 years higher than that recorded for females and 6 years higher for males had
the crisis not occurred.
Interpretation Our study shows that the eastern Mediterranean region is going through a crucial health phase. The
Arab uprisings and the wars that followed, coupled with ageing and population growth, will have a major impact on
the regionâs health and resources. The region has historically seen improvements in life expectancy and other health
indicators, even under stress. However, the current situation will cause deteriorating health conditions for many
countries and for many years and will have an impact on the region and the rest of the world. Based on our fi ndings,
we call for increased investment in health in the region in addition to reducing the confl icts
Prioritisation processes for programme implementation and evaluation in public health: A scoping review
BackgroundProgramme evaluation is an essential and systematic activity for improving public health programmes through useful, feasible, ethical, and accurate methods. Finite budgets require prioritisation of which programmes can be funded, first, for implementation, and second, evaluation. While criteria for programme funding have been discussed in the literature, a similar discussion around criteria for which programmes are to be evaluated is limited. We reviewed the criteria and frameworks used for prioritisation in public health more broadly, and those used in the prioritisation of programmes for evaluation. We also report on stakeholder involvement in prioritisation processes, and evidence on the use and utility of the frameworks or sets of criteria identified. Our review aims to inform discussion around which criteria and domains are best suited for the prioritisation of public health programmes for evaluation.MethodsWe reviewed the peer-reviewed literature through OVID MEDLINE (PubMed) on 11 March 2022. We also searched the grey literature through Google and across key websites including World Health Organization (WHO), US Centers for Disease Control and Prevention (CDC), European Centre for Disease Prevention and Control (ECDC), and the International Association of National Public Health Institutes (IANPHI) (14 March 2022). Articles were limited to those published between 2002 and March 2022, in English, French or German.ResultsWe extracted over 300 unique criteria from 40 studies included in the analysis. These criteria were categorised into 16 high-level conceptual domains to allow synthesis of the findings. The domains most frequently considered in the studies were âburden of diseaseâ (33 studies), âsocial considerationsâ (30 studies) and âhealth impacts of the interventionâ (28 studies). We only identified one paper which proposed criteria for use in the prioritisation of public health programmes for evaluation. Few prioritisation frameworks had evidence of use outside of the setting in which they were developed, and there was limited assessment of their utility. The existing evidence suggested that prioritisation frameworks can be used successfully in budget allocation, and have been reported to make prioritisation more robust, systematic, transparent, and collaborative.ConclusionOur findings reflect the complexity of prioritisation in public health. Development of a framework for the prioritisation of programmes to be evaluated would fill an evidence gap, as would formal assessment of its utility. The process itself should be formal and transparent, with the aim of engaging a diverse group of stakeholders including patient/public representatives
De-escalation strategies for non-pharmaceutical interventions following infectious disease outbreaks: a rapid review and a proposed dynamic de-escalation framework
BACKGROUND: The severity of COVID-19, as well as the speed and scale of its spread, has posed a global challenge. Countries around the world have implemented stringent non-pharmaceutical interventions (NPI) to control transmission and prevent health systems from being overwhelmed. These NPI have had profound negative social and economic impacts. With the timeline to worldwide vaccine roll-out being uncertain, governments need to consider to what extent they need to implement and how to de-escalate these NPI. This rapid review collates de-escalation criteria reported in the literature to provide a guide to criteria that could be used as part of de-escalation strategies globally. METHODS: We reviewed literature published since 2000 relating to pandemics and infectious disease outbreaks. The searches included Embase.com (includes Embase and Medline), LitCovid, grey literature searching, reference harvesting and citation tracking. Over 1,700 documents were reviewed, with 39 documents reporting de-escalation criteria included in the final analysis. Concepts retrieved through a thematic analysis of the included documents were interlinked to build a conceptual dynamic de-escalation framework. RESULTS: We identified 52 de-escalation criteria, the most common of which were clustered under surveillance (cited by 43 documents, 10 criteria e.g. ability to actively monitor confirmed cases and contact tracing), health system capacity (cited by 30 documents, 11 criteria, e.g. ability to treat all patients within normal capacity) and epidemiology (cited by 28 documents, 7 criteria, e.g. number or changes in case numbers). De-escalation is a gradual and bi-directional process, and resurgence of infections or emergence of variants of concerns can lead to partial or full re-escalation(s) of response and control measures in place. Hence, it is crucial to rely on a robust public health surveillance system. CONCLUSIONS: This rapid review focusing on de-escalation within the context of COVID-19 provides a conceptual framework and a guide to criteria that countries can use to formulate de-escalation plans
Prevalence and risk factors for long COVID and post-COVID-19 condition in Africa: a systematic review
Summary
Background An improved estimation of the clinical sequelae of SARS-CoV-2 infection is crucial in African countries,
where the subject has received little attention despite more than 12 million reported cases and evidence that many
more people were infected. We reviewed the evidence on prevalence, associated risk factors for long COVID, and
systemic or sociocultural determinants of reporting long COVID.
Methods We conducted a systematic review, searching PubMed, the Living OVerview of Evidence platform, and grey
literature sources for publications from Dec 1, 2019, to Nov 23, 2022. We included articles published in English,
French, Spanish, or Portuguese that reported on any study type in Africa with participants of any age who had
symptoms for 4 weeks or more after an acute SARS-CoV-2 infection. We excluded secondary research, comments,
and correspondence. Screening and data extraction were performed by two reviewers. Summary estimates were
extracted, including sociodemographic factors, medical history, prevalence of persistent symptoms, and symptoms
and associated factors. Results were analysed descriptively. The study was registered on the Open Science Framework
platform.
Findings Our search yielded 294 articles, of which 24 peer-reviewed manuscripts were included, reporting on
9712 patients from eight African countries. Only one study exclusively recruited children, and one other study
included children as part of their study population. Studies indicated moderate to low risk of bias. Prevalence of long
COVID varied widely, from 2% in Ghana to 86% in Egypt. Long COVID was positively associated with female sex,
older age, non-Black ethnicity, low level of education, and the severity of acute infection and underlying comorbidity.
HIV and tuberculosis were not identified as risk factors. Factors influencing reporting included absence of awareness,
inadequate clinical data and diagnostics, and little access to health-care services.
Interpretation In Africa, research on long COVID is scarce, particularly among children, who represent the majority
of the population. However, existing studies show a substantial prevalence across settings, emphasising the
importance of vaccination and other prevention strategies to avert the effects of long COVID on individual wellbeing,
the increased strain on health systems, and the potential negative effects on economically vulnerable populations. At
a global level, including African countries, tools for research on long COVID need to be harmonised to maximise the
usefulness of the data collected.
Funding NonePeer Reviewe
Public health effects of travel-related policies on the COVID-19 pandemic: A mixed-methods systematic review
Objectives: To map travel policies implemented due to COVID-19 during 2020, and conduct a mixed methods systematic review of health effects of such policies, and related contextual factors.
Design: Policy mapping and systematic review.
Data sources and Eligibility Criteria: for the policy mapping, we searched websites of relevant government bodies and used data from the Oxford COVID-19 Government Response Tracker for a convenient
sample of 31 countries across different regions. For the systematic review, we searched Medline (Ovid),
PubMed, EMBASE, the Cochrane Central Register of Controlled Trials and COVID-19 specific databases. We
included randomized controlled trial, non-randomized studies, modeling studies, and qualitative studies.
Two independent reviewers selected studies, abstracted data and assessed risk of bias.
Results: Most countries adopted a total border closure at the start of the pandemic. For the remainder
of the year, partial border closure banning arrivals from some countries or regions was the most widely
adopted measure, followed by mandatory quarantine and screening of travelers. The systematic search
identified 69 eligible studies, including 50 modeling studies. Both observational and modeling evidence
suggest that border closure may reduce the number of COVID-19 cases, disease spread across countries
and between regions, and slow the progression of the outbreak. These effects are likely to be enhanced
when implemented early, and when combined with measures reducing transmission rates in the community. Quarantine of travelers may decrease the number of COVID-19 cases but its effectiveness depends
on compliance and enforcement and is more effective if followed by testing, especially when less than 14
day-quarantine is considered. Screening at departure and/or arrival is unlikely to detect a large proportion
of cases or to delay an outbreak. Effectiveness of screening may be improved with increased sensitivity
of screening tests, awareness of travelers, asymptomatic screening, and exit screening at country source.
While four studies on contextual evidence found that the majority of the public is supportive of travel
restrictions, they uncovered concerns about the unintended harms of those policies.Peer Reviewe
Communicating risk during early phases of COVID-19: Comparing governing structures for emergency risk communication across four contexts
BackgroundEmergency risk communication (ERC) is key to achieving compliance with public health measures during pandemics. Yet, the factors that facilitated ERC during COVID-19 have not been analyzed. We compare ERC in the early stages of the pandemic across four socio-economic settings to identify how risk communication can be improved in public health emergencies (PHE).MethodsTo map and assess the content, process, actors, and context of ERC in Germany, Guinea, Nigeria, and Singapore, we performed a qualitative document review, and thematically analyzed semi-structured key informant interviews with 155 stakeholders involved in ERC at national and sub-national levels. We applied Walt and Gilson's health policy triangle as a framework to structure the results.ResultsWe identified distinct ERC strategies in each of the four countries. Various actors, including governmental leads, experts, and organizations with close contact to the public, collaborated closely to implement ERC strategies. Early integration of ERC into preparedness and response plans, lessons from previous experiences, existing structures and networks, and clear leadership were identified as crucial for ensuring message clarity, consistency, relevance, and an efficient use of resources. Areas of improvement primarily included two-way communication, community engagement, and monitoring and evaluation. Countries with recurrent experiences of pandemics appeared to be more prepared and equipped to implement ERC strategies.ConclusionWe found that considerable potential exists for countries to improve communication during public health emergencies, particularly in the areas of bilateral communication and community engagement as well as monitoring and evaluation. Building adaptive structures and maintaining long-term relationships with at-risk communities reportedly facilitated suitable communication. The findings suggest considerable potential and transferable learning opportunities exist between countries in the global north and countries in the global south with experience of managing outbreaks
- âŚ